Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

18.84 +0.39 (+2.09%)
Streaming Delayed Price Updated: 10:47 AM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
STAAR Surgical Patient Awareness Campaign Launched In New York
From STAAR Surgical Company
Via Business Wire
Top-Rated Stocks: Lantheus Stock Sees Composite Rating Climb To 96
Top-rated Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. 
Via Investor's Business Daily
Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating
On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before. 
Via Investor's Business Daily
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
Disney, Inotiv, Warby Parker And Some Other Big Stocks Moving Higher On Thursday
  Absci Corporation (NASDAQ: ABSI) jumped 38.8% to $5.83 after the company reported a narrower Q2 loss. 
Via Benzinga
Disney To $154? Here Are 5 Other Price Target Changes For Thursday
Keybanc boosted the price target on The Walt Disney Company (NYSE: DIS) from $131 to $154. Keybanc analyst Brandon Nispel maintained the stock with an Overweight rating. Disney shares rose 8.7% to... 
Via Benzinga
Leading Medical Stock Staar Surgical Jumps After Nabbing A Second-Quarter Beat
The company's second-quarter earnings and profit came in strong, leading shares to rise in late action Wednesday. 
Via Investor's Business Daily
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Second Quarter Results on August 10, 2022
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)
From STAAR Surgical Company
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're ready for another busy day of trading and kicking it off is a breakdown of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Austin Gold (NYSE: AUST) shares rose 30.3% to $5.70 in pre-market trading after gaining around 9% on Wednesday. Austin Gold had its IPO on Wednesday at $5 per share. 
Via Benzinga
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
From STAAR Surgical Company
Via Business Wire
Here's How Much You Would Have Made Owning Staar Surgical Stock In The Last 20 Years
Staar Surgical (NASDAQ:STAA) has outperformed the market over the past 20 years by 5.45% on an annualized basis producing an average annual return of 12.6%. Currently, Staar Surgical has a market... 
Via Benzinga
STAAR Surgical to Report First Quarter Results on May 4, 2022
From STAAR Surgical Company
Via Business Wire
Needham Sees Clear View Into STAAR Surgical's Durable Double-Digit Revenue Expansion
Needham is initiating coverage on STAAR Surgical Company (NASDAQ: STAA) with a Buy rating and an $87 price target. The analysts note that FDA approval of STAA... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022
Upgrades 
Via Benzinga
STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.
From STAAR Surgical Company
Via Business Wire
50 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron.... 
Via Benzinga
Why STAAR Surgical's Shares Are Gaining Today
The FDA approved STAAR Surgical Company's (NASDAQ: STAA) EVO/EVO+ Visian Implantable Collamer Lens to correct myopia and myopia with astigmatism. Myopia, also... 
Via Benzinga
Futures Reverse Overnight Losses As More Curves Invert, Yen Plummets To 7 Year Low
After initially sliding lower, US equity futures reversed and erased earlier declines, climbing 0.2% along with Nasdaq futures as Stoxx Europe 600 extends gains to 1.1%. 
Via Talk Markets
Staar Surgical Rockets After FDA Clears Its Implantable Lens For Nearsightedness
Staar Surgical won Food and Drug Administration clearance for its implantable nearsightedness lens on Monday, leading STAA stock to soar. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers OncoSec Medical (NASDAQ:ONCS) shares moved upwards by 27.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $59.0 million.... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! It's time to start off the week with an overview of the biggest pre-market stock movers for Monday! 
Via InvestorPlace
22 Stocks Moving in Monday's Pre-Market Session
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 27.3% to $1.63 in pre-market trading. Last week, AMC Entertainment Holdings purchased a major stake in Hycroft Mining Holding. 
Via Benzinga
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
From STAAR Surgical Company
Via Business Wire
BTIG Upgraded Staar Surgical Stock - Read Why
BTIG upgraded Implantable lenses-focused Staar Surgical Company (NASDAQ: STAA) to Buy from Neutral with a $98 price target. Analyst Ryan Zimmerman believes... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.